Larry Robbins's DNA Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 149,379 shares of Ginkgo Bioworks Holdings, Inc. (DNA) worth $1.24 M, representing 0.03% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Larry Robbins has maintained this position in DNA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2024, adding 62,500 shares. Largest reduction occurred in Q4 2024, reducing 287,497 shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Ginkgo Bioworks Holdings (DNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ginkgo Bioworks Holdings (DNA) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | -38,122 | Reduce 20.33% | 149,379 | $11.25 |
| Q4 2024 | -287,497 | Reduce 60.53% | 187,501 | $9.82 |
| Q3 2024 | -187,502 | Reduce 28.30% | 474,998 | $8.15 |
| Q2 2024 | +62,500 | Add 10.42% | 662,500 | $13.37 |
| Q1 2024 | +600,000 | New Buy | 600,000 | $46.40 |
Larry Robbins's Ginkgo Bioworks Holdings Investment FAQs
Larry Robbins first purchased Ginkgo Bioworks Holdings, Inc. (DNA) in Q1 2024, acquiring 600,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Ginkgo Bioworks Holdings, Inc. (DNA) for 8 quarters since Q1 2024.
Larry Robbins's largest addition to Ginkgo Bioworks Holdings, Inc. (DNA) was in Q1 2024, adding 600,000 shares worth $27.84 M.
According to the latest 13F filing for Q4 2025, Larry Robbins's firm, Glenview Capital Management, LLC, owns 149,379 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $1.24 M.
As of the Q4 2025 filing, Ginkgo Bioworks Holdings, Inc. (DNA) represents approximately 0.03% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Ginkgo Bioworks Holdings, Inc. (DNA) was 662,500 shares, as reported at the end of Q2 2024.